Show simple item record

dc.contributor.authorHuỳnh, Christophe
dc.contributor.authorKisely, Steve
dc.contributor.authorRochette, Louis
dc.contributor.authorPelletier, Éric
dc.contributor.authorMorrison, Kenneth B
dc.contributor.authorLi, Shelley
dc.contributor.authorHopkin, Gareth
dc.contributor.authorSmith, Mark
dc.contributor.authorBurchill, Charles
dc.contributor.authorLin, Elizabeth
dc.contributor.authorAsbridge, Mark
dc.contributor.authorJutras-Aswad, Didier
dc.contributor.authorLesage, Alain
dc.date.accessioned2021-10-18T06:50:02Z
dc.date.available2021-10-18T06:50:02Z
dc.date.issued2021
dc.identifier.issn0706-7437
dc.identifier.doi10.1177/07067437211043446
dc.identifier.urihttp://hdl.handle.net/10072/409196
dc.description.abstractCONTEXT: Assessing temporal changes in the recorded diagnostic rates, incidence proportions, and health outcomes of substance-related disorders (SRD) can inform public health policymakers in reducing harms associated with alcohol and other drugs. OBJECTIVE: To report the annual and cumulative recorded diagnostic rates and incidence proportions of SRD, as well as mortality rate ratios (MRRs) by cause of death among this group in Canada, according to their province of residence. METHODS: Analyses were performed on linked administrative health databases (AHD; physician claims, hospitalizations, and vital statistics) in five Canadian provinces (Alberta, Manitoba, Ontario, Québec, and Nova Scotia). Canadians 12 years and older and registered for their provincial healthcare coverage were included. The International Classification of Diseases (ICD-9 or ICD-10 codes) was used for case identification of SRD from April 2001 to March 2018. RESULTS: During the study period, the annual recorded SRD diagnostic rates increased in Alberta (2001-2002: 8.0‰; 2017-2018: 12.8‰), Ontario (2001-2002: 11.5‰; 2017-2018: 14.4‰), and Nova Scotia (2001-2002: 6.4‰; 2017-2018: 12.7‰), but remained stable in Manitoba (2001-2002: 5.5‰; 2017-2018: 5.4‰) and Québec (2001-2002 and 2017-2018: 7.5‰). Cumulative recorded SRD diagnostic rates increased steadily for all provinces. Recorded incidence proportions increased significantly in Alberta (2001-2002: 4.5‰; 2017-2018: 5.0‰) and Nova Scotia (2001-2002: 3.3‰; 2017-2018: 3.8‰), but significantly decreased in Ontario (2001-2002: 6.2‰; 2017-2018: 4.7‰), Québec (2001-2002: 4.1‰; 2017-2018: 3.2‰) and Manitoba (2001-2002: 2.7‰; 2017-2018: 2.0‰). For almost all causes of death, a higher MRR was found among individuals with recorded SRD than in the general population. The causes of death in 2015-2016 with the highest MRR for SRD individuals were SRD, suicide, and non-suicide trauma in Alberta, Ontario, Manitoba, and Québec. DISCUSSION: Linked AHD covering almost the entire population can be useful to monitor the medical service trends of SRD and, therefore, guide health services planning in Canadian provinces.
dc.description.peerreviewedYes
dc.languageeng
dc.publisherSage Publications Ltd
dc.relation.ispartofjournalThe Canadian Journal of Psychiatry
dc.subject.fieldofresearchBiomedical and clinical sciences
dc.subject.fieldofresearchPsychology
dc.subject.fieldofresearchcode32
dc.subject.fieldofresearchcode52
dc.subject.keywordsCanada
dc.subject.keywordsalcohol-related disorders
dc.subject.keywordshealthcare administrative claims
dc.subject.keywordsinternational classification of diseases
dc.subject.keywordspremature mortality
dc.titleMeasuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios: Mesurer les troubles liés aux substances à l’aide des banques de données de santé administratives canadiennes: comparaisons interprovinciales des taux diagnostiques enregistrés, proportions de l’incidence et rapports des taux de mortalité
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationHuỳnh, C; Kisely, S; Rochette, L; Pelletier, É; Morrison, KB; Li, S; Hopkin, G; Smith, M; Burchill, C; Lin, E; Asbridge, M; Jutras-Aswad, D; Lesage, A, Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios: Mesurer les troubles liés aux substances à l’aide des banques de données de santé administratives canadiennes: comparaisons interprovinciales des taux diagnostiques enregistrés, proportions de l’incidence et rapports des taux de mortalité, The Canadian Journal of Psychiatry, 2021
dc.date.updated2021-10-18T03:51:23Z
dc.description.versionAccepted Manuscript (AM)
gro.description.notepublicThis publication has been entered as an advanced online version in Griffith Research Online.
gro.rights.copyrightHuỳnh, C et al., Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios: Mesurer les troubles liés aux substances à l’aide des banques de données de santé administratives canadiennes: comparaisons interprovinciales des taux diagnostiques enregistrés, proportions de l’incidence et rapports des taux de mortalité,The Canadian Journal of Psychiatry, 2021. Copyright 2021 The Authors. Reprinted by permission of SAGE Publications.
gro.hasfulltextFull Text
gro.griffith.authorKisely, Steve R.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record